Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate

Pharmaceutical Development and Technology

Volumn 3, Issue 4, 1998, Pages 587-596

  Man, Jun ^a   Suryanarayanan, Raj ^b  

^a Oread Laboratories Inc   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Carbamazepine; Dehydration; Differential scanning calorimetry (DSC); Polymorphs; Thermogravimetric analysis (TGA); Water vapor pressure; X ray diffractometry (XRD)

Indexed keywords

CARBAMAZEPINE;

ARTICLE; DATA ANALYSIS; DEHYDRATION; DIFFERENTIAL SCANNING CALORIMETRY; ENVIRONMENTAL FACTOR; PRIORITY JOURNAL; THERMOGRAVIMETRY; WATER VAPOR; X RAY DIFFRACTION;

EID: 7844230223     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459809028643     Document Type: Article

References (38)

1. J. K. Haleblian, Characterization of habits and crystalline modification of solids and their pharmaceutical applications, J. Pharm. Sci., 64, 1269-1288 (1975).
2. J. K. Haleblian and W. McCrone, Pharmaceutical applications of polymorphism, J. Pharm. Sci., 58, 911-929 (1969).
3. G. Zografi, States of water associated with solids, Drug Dev. Ind. Pharm., 14, 1905-1926 (1988).
4. The United States Pharmacopeia, XXIII revision, United States Pharmacopeial Convention, Rockville, MD, 1994.
5. S. R. Byrn, Solid-State Chemistry of Drugs, Academic Press, New York, NY, 1982.
6. S. R. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg, and G. Poochikian, Pharmaceutical solids: A strategic approach to regulatory considerations, Pharm. Res., 12, 945-954 (1995).
7. 2O, J. Chem. Soc., 321-325 (1935).
8. W. E. Garner, Kinetics of endothermic solid reactions. In W. E. Garner (ed.), Chemistry of the Solid State, Academic Press, New York, NY, 1955.
9. J. A. Lumpkin and D. D. Perlmutter, Thermal and water vapor effects on the rate of the dehydration reactions of barium chloride, Thermochim. Acta, 249, 335-349 (1995).
10. J. Han and R. Suryanarayanan, Applications of pressure differential scanning calorimetry in the study of pharmaceutical hydrates. 1. carbamazepine dihydrate, Int. J. Pharm., 157, 209-218 (1997).
11. R. K. Khankari and D. J. W. Grant, Pharmaceutical hydrates. Thermochim. Acta, 248, 61-79 (1995).
12. H. Kitaoka, K. Ohya, and H. Hakusui, Thermal dehydration of nafagrel hydrochloride hydrate at controlled water vapor partial pressures, Chem. Pharm. Bull., 43, 1744-1750 (1995).
13. U. J. Giesser and A. Burger, The effect of water vapor pressure on desolvation kinetics of caffeine 4/5-hydrate, Int. J. Pharm., 120, 83-93 (1995).
14. M. T. Ledwidge and O. I. Corrigan, Effects of environmental factors on the dehydration of diclofenac HEP dihydrate and theophylline monohydrate, Int. J. Pharm., 147, 41-49 (1997).
15. N. Z. Lyakhov and V. V. Boldyrev, Kinetics and mechanism of the dehydration of crystal hydrates, Russian Chem. Rev., 41, 919-928 (1972).
16. S. Budaveri (ed.), The Merck Index, 12th ed., Merck and Co., Whitehouse Station, N.J., 1996, p. 290.
17. M. M. J. Lowes, M. R. Caira, A. P. Lotter, and J. G. Van Der Watt, Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine, J. Pharm. Sci., 76, 744-752 (1987).
18. H. Pöhlmann, C. Gulde, R. Jahn, and S. Pfeifer, Polymorphism, particle size, and blood concentrations of carbamazepine, Pharmazie, 30, 709-711 (1975).
19. T. Umeda, N. Ohnishi, T. Yokoyama, K. Kuroda, T. Kuroda, E. Tatsumi, and Y. Matsuda, Kinetics of the thermal transition of carbamazepine polymorphic forms in the solid state, Yakugaku Zasshi, 104, 786-792 (1984).
20. J. Dugué, R. Céolin, J. C. Rouland, and F. Lepage, Polymorphism of carbamazepine: Solid-state studies on carbamazepine dihydrate, Pharm. Acta Helv., 66, 307-310 (1991).
21. F. U. Krahn and J. B. Mielck, Relations between several polymorphic forms and the dihydrate of carbamazepine, Pharm. Acta Helv., 62, 247-254 (1987).
22. 2O) in a mixture by powder X-ray diffractometry, Pharm. Res., 6, 1017-1024 (1989).
23. L. E. McMahon, P. Timmins, A. C. Williams, and P. York, Characterization of dihydrates prepared from carbamazepine polymorphs, J. Pharm. Sci., 85, 1064-1069 (1996).
24. J. P. Reboul, B. Cristau, J. C. Soyfer, and J. P. Astier, 5H-Dibenz[b,f]azépinecarboxzmide-5 (Carbamazépine), Acta Crystallogr., B37, 1844-1848 (1981).
25. V. L. Himes, A. D. Mighell, and W. H. De Camp, Structure of carbamazepine: 5H-Dibenz[b,f]azepine-5-carboxamide, Acta Crystallogr., B37, 2242-2245 (1981).
26. R. Ceolin, S. Toscani, M. Cardette, V. N. Agafonov, A. V. Dzyabchenko, and B. Bachet, X-ray characterization of the triclinic polymorph of carbamazepine, J. Pharm. Sci., 86, 1062-1065 (1997).
27. 2O, Cryst. Res. Technol., 21, 1463-1468 (1986).
28. J. Han, Influence of environmental conditions on the dehydration of pharmaceutical hydrates, Ph.D. dissertation, University of Minnesota (1998).
29. Du Pont Films, Film Selector Guide - For DuPont Mylar® Polyester Film, Du Pont, 1995.
30. J. H. Sharp, G. W. Brindley, and B. N. N. Achar, Numerical data for some commonly used solid state reaction equations, J. Am. Ceram. Soc., 52, 781-791 (1963).
31. D. C. Monkhouse and L. Van Campen, Solid state reactions - Theoretical and experimental aspects, Drug Dev. Ind. Pharm., 10, 1175-1276 (1984).
32. C. Ahlneck and G. Zografi. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state, Int. J. Pharm., 62, 87-95 (1990).
33. R. C. Wheeler and G. B. Frost, A comparative study of the dehydration kinetics of several hydrated salts, Canad. J. Chem., 33, 546-561 (1955).
34. M. Avrami, Kinetics of phase change: I, J. Chem. Phys., 7, 1103-1112 (1939).
35. M. Avrami, Kinetics of phase change: II, J. Chem. Phys., 8, 212-224 (1940).
36. M. Avrami, Kinetics of phase change: III, J. Chem. Phys., 9, 177-184 (1941).
37. V. Andronis, M. Yoshioka, and G. Zografi, Effects of sorbed water on the crystallization of indomethacin from the amorphous state, J. Pharm. Sci., 86, 346-351 (1997).
38. M. Yoshioka, B. C. Hancock, and G. Zografi, Crystallization of indomethacin from the amorphous state below and above its glass transition temperature, J. Pharm. Sci., 83, 1700-1705 (1994).